Core Viewpoint - China Pharmaceutical University has announced procurement intentions for 26 items of laboratory equipment, with a total budget of 114 million yuan, scheduled for procurement between June and November 2025 [2][3]. Group 1: Procurement Overview - The procurement includes advanced biomedical research equipment such as small animal 3D optical imaging systems, small animal in vivo cell dynamic analysis imaging, small animal irradiation devices, and small animal MRI systems [3][4][6]. - The total budget for the procurement is 114 million yuan, indicating significant investment in research capabilities [2][3]. Group 2: Specific Equipment Details - **Small Animal 3D Optical Imaging System**: This device allows non-invasive, real-time 3D imaging of small experimental animals, widely used in oncology, immunology, and drug development [4]. - **Small Animal Irradiation Device**: Designed for precise radiation exposure of cells and small animals, applicable in cancer biology and stem cell research [5]. - **Small Animal MRI System**: Provides high-resolution imaging for observing structural and functional changes in small animals, crucial for biomedical research [6]. Group 3: Research and Development Impact - The procurement aims to enhance the university's research capabilities in various fields, including drug development, cancer research, and molecular biology [4][5][6]. - The investment reflects the university's commitment to advancing biomedical research and its role as a leader in pharmaceutical education and innovation in China [12][28].